Article info
Commentary
Putting GWAS to the functional test: NR5A2 and pancreatic cancer risk
- Correspondence to L Charles Murtaugh, Department of Human Genetics, University of Utah, 15 North 2030 East, Room 2100, Salt Lake City, UT 84112, USA; murtaugh{at}genetics.utah.edu
Citation
Putting GWAS to the functional test: NR5A2 and pancreatic cancer risk
Publication history
- Received May 20, 2013
- Accepted May 21, 2013
- First published June 12, 2013.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions